2014
DOI: 10.4236/pst.2014.21002
|View full text |Cite
|
Sign up to set email alerts
|

Symptomatic improvement in an acute, non-traumatic spine pain model with a combination of uridine triphosphate, cytidine monophosphate, and hydroxocobalamin

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
0
0
1

Year Published

2017
2017
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(3 citation statements)
references
References 15 publications
0
0
0
1
Order By: Relevance
“…In the last two decades, many studies concluded the effectiveness and safety of vitamin B and nucleotides (alone or in combination with vitamin B12) in combating neuropathic pain and regeneration of peripheral nerves, but no study was performed in L.R.S. patients [28]. Furthermore, unlike other combinations, PHSD contains vitamin D, with a complex role in the human body.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In the last two decades, many studies concluded the effectiveness and safety of vitamin B and nucleotides (alone or in combination with vitamin B12) in combating neuropathic pain and regeneration of peripheral nerves, but no study was performed in L.R.S. patients [28]. Furthermore, unlike other combinations, PHSD contains vitamin D, with a complex role in the human body.…”
Section: Discussionmentioning
confidence: 99%
“…It has demonstrated the effectiveness of administering medications containing pyrimidine nucleotides (uridine triphosphate -U.T.P., cytidine monophosphate -C.M.P.) in reducing pain intensity associated with diabetic neuropathy, back pain, cervical pain, and trauma-compressive disorders [27], with neuro regenerative properties in the medium term [28]. The use of uridine and cytidine nucleotides associated with hydroxocobalamin had positive control of the intensity of chronic neuropathic low back pain, with a reduction in the consumption of rescue analgesics, thus improving and enhancing the quality of treatment [27,29], and in reducing the pain and improving the motor activity of the patients with alcoholic polyneuropathy [30].…”
Section: Introductionmentioning
confidence: 99%
“…В последующем было проведено двойное слепое рандомизированное сравнительное исследование с участием пациентов с ПБ, БС в области бедра и шеи нетравматического характера [23]. Все больные были рандомизированы на 2 группы: 40 пациентов 1-й группы (группа Д) получали комбинацию препаратов диклофенак-холестирамин 1 раз в сутки, 1,5 мг уридинтрифосфата (УТФ), 2,5 мг цитидинмонофосфата (ЦМФ) и 1 мг гидроксокобаламина 3 раза в сутки; 41 пациент 2-й группы получал 1,5 мг УТФ, 2,5 мг ЦМФ и 1 мг гидроксокобаламина 3 раза в сутки.…”
Section: эффективность витаминов группы в при пероральном назначенииunclassified